Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Zentralblatt Fur Chirurgie|January 1, 1997
[Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas]A R Börner, H W Müller-GärtnerNuklearmedizin. Nuclear Medicine|February 13, 1999
[F-18-FDG PET in autonomous goiter]A R Börner, E Voth, K Wienhard, et al.Nuklearmedizin. Nuclear Medicine|November 27, 1998
[F-qi-FDG PET of the thyroid gland in Graves' disease]A R Börner, E Voth, K Wienhard, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2002
Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinomaT Petrich, A R Börner, D Otto, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2001
[The value of positron emission tomography (PET) in the treatment of patients with cancer of unknown primary (CUP)]D Rades, G Kühnel, I Wildfang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic managementD Rades, G Kühnel, I Wildfang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumorsK J Langen, A R Börner, V Müller-Mattheis, et al.Nuclear Medicine and Biology|April 27, 2001
Whole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-prolineA R Börner, K J Langen, H Herzog, et al.Nuklearmedizin. Nuclear Medicine|May 26, 2001
[Follow-up of differentiated thyroid cancer patients using rhTSH--preliminary results]T Petrich, A R Börner, E Weckesser, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2001
[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PETJ van den Hoff, W Burchert, A R Börner, et al.Pageof 1